Skip to main content
. Author manuscript; available in PMC: 2017 May 13.
Published in final edited form as: Pediatr Blood Cancer. 2016 Apr 15;63(8):1368–1374. doi: 10.1002/pbc.26002

Fig. 4.

Fig. 4

Recommendations of the PMTB. PMTB successfully provided recommendations based on molecular profling results in the majority of the reviewed cases. Only a minority of cases for which alterations in therapy were made had clinical evidence to support therapeutic recommendations (levels 1–2).